Research Summary
Pruritus therapeutics refers to the branch of medical treatments specifically focused on addressing pruritus, which is the medical term for itching. Pruritus can be associated with various conditions, including dermatological disorders, systemic diseases, or neurological issues, and effective therapeutics aim to alleviate or manage the underlying causes of itching. Treatment approaches may include topical medications, systemic drugs, antihistamines, corticosteroids, or other pharmacological interventions. Additionally, therapies may be directed towards addressing the primary condition causing pruritus, whether it be a skin disorder, allergic reaction, or an internal medical issue. Non-pharmacological interventions such as moisturizers, cool compresses, and behavioral strategies may also be employed to provide relief. Given the diverse range of conditions associated with pruritus, an individualized approach to therapy is often necessary to effectively manage and alleviate itching symptoms.
According to DIResearch's in-depth investigation and research, the global Pruritus Therapeutics market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Pruritus Therapeutics include Johnson & Johnson, Abbott, Amgen, Novartis, LEO Pharma, Bayer, Pfizer, UCB Pharma, GlaxoSmithKline, Galderma, Huapont etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Pruritus Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Pruritus Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Pruritus Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Pruritus Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Pruritus Therapeutics Include:
Johnson & Johnson
Abbott
Amgen
Novartis
LEO Pharma
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
Pruritus Therapeutics Product Segment Include:
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Others
Pruritus Therapeutics Product Application Include:
External Use
Oral
Injection
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Pruritus Therapeutics Industry PESTEL Analysis
Chapter 3: Global Pruritus Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global Pruritus Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Pruritus Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Pruritus Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Pruritus Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Pruritus Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Pruritus Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Pruritus Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Pruritus Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Pruritus Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Pruritus Therapeutics Market Overview 1.1 Product Definition and Statistical Scope 1.2 Pruritus Therapeutics Product by Type 1.2.1 Global Pruritus Therapeutics Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Antihistamines 1.2.3 Corticosteroids 1.2.4 Calcineurin Inhibitors 1.2.5 Others 1.3 Pruritus Therapeutics Product by Application 1.3.1 Global Pruritus Therapeutics Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 External Use 1.3.3 Oral 1.3.4 Injection 1.4 Global Pruritus Therapeutics Market Revenue Analysis (2019-2030) 1.5 Pruritus Therapeutics Market Development Status and Trends 1.5.1 Pruritus Therapeutics Industry Development Status Analysis 1.5.2 Pruritus Therapeutics Industry Development Trends Analysis 2 Pruritus Therapeutics Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Pruritus Therapeutics Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Pruritus Therapeutics Market Analysis by Regions 4.1 Pruritus Therapeutics Overall Market: 2023 VS 2024 VS 2030 4.2 Global Pruritus Therapeutics Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Pruritus Therapeutics Revenue and Market Share by Region (2019-2024) 4.2.2 Global Pruritus Therapeutics Revenue Forecast by Region (2025-2030) 5 Global Pruritus Therapeutics Market Size by Type and Application 5.1 Global Pruritus Therapeutics Market Size by Type 5.2 Global Pruritus Therapeutics Market Size by Application 6 North America 6.1 North America Pruritus Therapeutics Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Pruritus Therapeutics Market Size by Type 6.4 North America Pruritus Therapeutics Market Size by Application 6.5 North America Pruritus Therapeutics Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Pruritus Therapeutics Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Pruritus Therapeutics Market Size by Type 7.4 Europe Pruritus Therapeutics Market Size by Application 7.5 Europe Pruritus Therapeutics Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Pruritus Therapeutics Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Pruritus Therapeutics Market Size by Type 8.4 China Pruritus Therapeutics Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Pruritus Therapeutics Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Pruritus Therapeutics Market Size by Type 9.4 APAC (excl. China) Pruritus Therapeutics Market Size by Application 9.5 APAC (excl. China) Pruritus Therapeutics Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Pruritus Therapeutics Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Pruritus Therapeutics Market Size by Type 10.4 Latin America Pruritus Therapeutics Market Size by Application 10.5 Latin America Pruritus Therapeutics Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Pruritus Therapeutics Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Pruritus Therapeutics Market Size by Type 11.4 Middle East & Africa Pruritus Therapeutics Market Size by Application 11.5 Middle East & Africa Pruritus Therapeutics Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Pruritus Therapeutics Market Revenue by Key Manufacturers (2020-2024) 12.2 Pruritus Therapeutics Competitive Landscape Analysis and Market Dynamic 12.2.1 Pruritus Therapeutics Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Johnson & Johnson 13.1.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Johnson & Johnson Pruritus Therapeutics Product Portfolio 13.1.3 Johnson & Johnson Pruritus Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Abbott 13.2.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Abbott Pruritus Therapeutics Product Portfolio 13.2.3 Abbott Pruritus Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Amgen 13.3.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Amgen Pruritus Therapeutics Product Portfolio 13.3.3 Amgen Pruritus Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Novartis 13.4.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Novartis Pruritus Therapeutics Product Portfolio 13.4.3 Novartis Pruritus Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 LEO Pharma 13.5.1 LEO Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 LEO Pharma Pruritus Therapeutics Product Portfolio 13.5.3 LEO Pharma Pruritus Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Bayer 13.6.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Bayer Pruritus Therapeutics Product Portfolio 13.6.3 Bayer Pruritus Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Pfizer 13.7.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Pfizer Pruritus Therapeutics Product Portfolio 13.7.3 Pfizer Pruritus Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 UCB Pharma 13.8.1 UCB Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 UCB Pharma Pruritus Therapeutics Product Portfolio 13.8.3 UCB Pharma Pruritus Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 GlaxoSmithKline 13.9.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 GlaxoSmithKline Pruritus Therapeutics Product Portfolio 13.9.3 GlaxoSmithKline Pruritus Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Galderma 13.10.1 Galderma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Galderma Pruritus Therapeutics Product Portfolio 13.10.3 Galderma Pruritus Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Huapont 13.11.1 Huapont Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Huapont Pruritus Therapeutics Product Portfolio 13.11.3 Huapont Pruritus Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Pruritus Therapeutics Industry Chain Analysis 14.2 Pruritus Therapeutics Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Pruritus Therapeutics Typical Downstream Customers 14.4 Pruritus Therapeutics Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Intrauterine Devices Market By Product Type (Hormonal Intrauterine Device and Copper Intrauterine Device), By Material (Plastic, Copper and Hormonal (Levonorgestrel)), By Age Group (15-24 years, 25-34 years, 35-44 years and Above 44 years), By End-user (Hospital, Gynecology Clinics, Community Health Care Centers and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Arterial Thrombectomy Devices Market By Device Type (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Rheolytic Thrombectomy Devices, Ultrasound-Assisted Thrombectomy Devices, Laser-Based Thrombectomy Devices, Others), By Application (Peripheral Arterial Disease (PAD), Coronary Artery Disease (CAD), Ischemic Stroke, Renal Artery Thrombosis, Acute limb Ischemia, Others), By End-user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Academic and Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Global Operating Room Infection Control Consumable Competitive Landscape Professional Research Report 2024
- Global Oral Fluid Drug Test System Competitive Landscape Professional Research Report 2024
- Global Orthopaedics Competitive Landscape Professional Research Report 2024
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support